"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Current Issue

How the health reform is looking out for the industry in the long-term.

E-magazine
  • Previous Issues

Blog

Spencer Green
Chairman, GDS International

Sales and the 'Talent Magnet'

A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?
26 May 2011
Comments (Total 1 Comments)
Steven Potts
Posted: 15 September 2010 @ 17:39

Most companion diagnostics approaches will involve more than one analyte, which are known as In Vitro Diagnostic Multi Analyte Assays (IVDMIAs). There is considerable discussion in the regulatory community on the best approach for validation and regulatory approval for IVDMIAs in <a href="http://www.flagshipbio.com/services-2/tissue-biomarker-development/">Companion Diagnostics</a>. These IVDIMAs may even mix serological assays with <a href="http://www.flagshipbio.com/services-2/whole-tissue-analysis/">tissue biomarkers</a>

Disclaimer: All comments posted in a personal capacity